These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20402384)

  • 21. Clinical applications of mesenchymal stem cells.
    Kim N; Cho SG
    Korean J Intern Med; 2013 Jul; 28(4):387-402. PubMed ID: 23864795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing.
    Hong HS; Kim YH; Son Y
    Arch Pharm Res; 2012 Feb; 35(2):201-11. PubMed ID: 22370775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles.
    Rad F; Ghorbani M; Mohammadi Roushandeh A; Habibi Roudkenar M
    Mol Biol Rep; 2019 Feb; 46(1):1533-1549. PubMed ID: 30623280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methodology, biology and clinical applications of human mesenchymal stem cells.
    Camassola M; de Macedo Braga LM; Chagastelles PC; Nardi NB
    Methods Mol Biol; 2012; 879():491-504. PubMed ID: 22610579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mesenchymal stem cells and the immune system--immunosuppression without drugs?].
    Kiss J; Urbán VS; Dudics V; Vas V; Uher F
    Orv Hetil; 2008 Feb; 149(8):339-46. PubMed ID: 18281229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stromal cells: current understanding and clinical status.
    Salem HK; Thiemermann C
    Stem Cells; 2010 Mar; 28(3):585-96. PubMed ID: 19967788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases.
    Chen Y; Yu Q; Hu Y; Shi Y
    Curr Stem Cell Res Ther; 2019; 14(7):579-582. PubMed ID: 31729289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunoregulatory function of mesenchymal stem cells and application of mesenchymal stem cells in therapy of autoimmune disease].
    Kong WX; Jiang XX; Mao N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1605-8. PubMed ID: 20030957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.
    Zhao S; Wehner R; Bornhäuser M; Wassmuth R; Bachmann M; Schmitz M
    Stem Cells Dev; 2010 May; 19(5):607-14. PubMed ID: 19824807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive properties of mesenchymal stem cells.
    Abumaree M; Al Jumah M; Pace RA; Kalionis B
    Stem Cell Rev Rep; 2012 Jun; 8(2):375-92. PubMed ID: 21892603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases.
    Zaripova LN; Midgley A; Christmas SE; Beresford MW; Pain C; Baildam EM; Oldershaw RA
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside.
    Saidi RF; Moghadasali R; Shekarchian S
    Iran J Kidney Dis; 2019 Jul; 13(4):213-224. PubMed ID: 31422386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation.
    Gieseke F; Kruchen A; Tzaribachev N; Bentzien F; Dominici M; Müller I
    Eur J Immunol; 2013 Oct; 43(10):2741-9. PubMed ID: 23817958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mesenchymal stem/stromal cells. Its therapeutic potential in medicine].
    Domínguez LM; Fiore EJ; Mazzolini GD
    Medicina (B Aires); 2020; 80(6):696-702. PubMed ID: 33254115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of mesenchymal stem cells in immunological rejection of organ transplantation.
    Zhang X; Jiao C; Zhao S
    Stem Cell Rev Rep; 2009 Dec; 5(4):402-9. PubMed ID: 19543842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?
    Mishra PK
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):122-8. PubMed ID: 18192802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.